Clinical Trials Logo

Esophageal Diseases clinical trials

View clinical trials related to Esophageal Diseases.

Filter by:

NCT ID: NCT05311787 Recruiting - ERAS Clinical Trials

The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery

Start date: January 2011
Phase: N/A
Study type: Interventional

Application of the perioperative enhanced recovery protocol has allowed to carry out esophagectomy to the patients with severe comorbidities and has led reducing the risks of severe postoperative complications.

NCT ID: NCT05252078 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

ALTER-E005
Start date: June 2, 2022
Phase: Phase 2
Study type: Interventional

This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma (ESCC) Patients as Postoperative Adjuvant Therapy. In order to observe and evaluate the efficacy and safety of Anlotinib Hydrochloride Capsules combined with TQB2450 Injection in treatment of patients with ESCC. The primary endpoint is disease free survival (DFS).

NCT ID: NCT05204901 Completed - Clinical trials for Gastrointestinal Diseases

Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care

Start date: May 4, 2022
Phase: N/A
Study type: Interventional

This is a trial on the feasibility of magnetic tracking for the confirmation of nasogastric tube location in human patients.

NCT ID: NCT05182255 Recruiting - Esophageal Diseases Clinical Trials

Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

Start date: April 28, 2022
Phase:
Study type: Observational

The aim of this post-market clinical follow-up study is to evaluate the continued safety and performance of the marketed Evolution® Esophageal Stent System (Partially- and Fully Covered).

NCT ID: NCT05054933 Recruiting - Esophageal Diseases Clinical Trials

Ultrasound Capsule Endoscopy for Esophagus Examination

Start date: September 26, 2021
Phase: N/A
Study type: Interventional

The aim of this pilot study is to assess the feasibility and safety of the clinical application of ultrasound capsule endoscopy in esophageal examination compared with conventional endoscopic ultrasound examination.

NCT ID: NCT05004155 Recruiting - Esophagitis Clinical Trials

Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population

Start date: June 1, 2021
Phase:
Study type: Observational

GERD is common in Indian population and the normative data which is used to diagnose & manage GERD and its complications are based on western data which is not validated in the Indian population. Although normative data is available for commonly used twenty-four impedance-pH parameters, their global application has limitations, stemming from use of small healthy volunteer cohorts from few countries for normative data. At present, there is no normative data for twenty-four hours impedance-pH monitoring in Indian population. The aim of this study is to obtain a new set of normal values specific for the Indian population.

NCT ID: NCT04759378 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Comorbid Esophageal Disorders in IBS Patients

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

assess the incidence of the entire spectrum of esophageal disorders and possible theories for overlap in IBS patients using different diagnostic modalities.

NCT ID: NCT04649372 Completed - Gastric Cancer Clinical Trials

EndoVE endosCopic Treatment for Oesophageal and Gastric canceR

VECTOR
Start date: January 13, 2021
Phase: N/A
Study type: Interventional

This project aims to establish the safety and efficacy of treating patients with inoperable oesophageal cancer or gastric cancer, using an endoscopic electroporation system (EndoVE) to facilitate direct chemotherapy tumour absorption.

NCT ID: NCT04481100 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of concurrent chemoradiotherapy combined with Itraconazole in patients with locally adcvanced esophageal squamous cancer

NCT ID: NCT04312633 Recruiting - Barrett Esophagus Clinical Trials

Clinical Utility of WATS3D: A 5-Year Prospective Study

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach). The two methods of sampling are: 1) Using forceps that take biopsies (small tissue samples) from your esophagus, and 2) Using a brush that also takes biopsies from your esophagus.